Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage
Keywords: پلاکت ها; GPIIb/IIIa; platelet glycoprotein (GP) IIb/IIIa; PCI; percutaneous coronary intervention; ACS; acute coronary syndromes; NSTE; non-ST-segment elevation; MI; myocardial infarction; PRP; platelet-rich-plasma; PPP; platelet-poor plasma; Tirofiban; Clopidogre